​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker (SYK) stock forecast, based on 52 Wall Street analysts, predicts a 12-month average price target of $365.89, with a high of $420.00 and a low of $310.00. This represents a 24.17% increase from the last price of $294.66.

$250 $290 $330 $370 $410 $450 High: $420 Avg: $365.89 Low: $310 Last Closed Price: $294.66

SYK Stock Rating

Stryker stock's rating consensus is Buy, based on 52 Wall Street analysts. The breakdown includes 1 Strong Buy (1.92%), 36 Buy (69.23%), 15 Hold (28.85%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 52 15 36 1 Strong Sell Sell Hold Buy Strong Buy

SYK Price Target Upside V Benchmarks

TypeNameUpside
StockStryker24.17%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.88%

Price Target Trends

1M3M12M
# Anlaysts41241
Avg Price Target$332.75$357.83$387.73
Last Closing Price$294.66$294.66$294.66
Upside/Downside12.93%21.44%31.59%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 267156--28
Sep, 267156--28
Aug, 267165--28
Jul, 267146--27
Jun, 267147--28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 12, 2026Ryan ZimmermanBTIG$316.00$279.8312.93%7.24%
Oct 06, 2026Barclays$375.00$278.5034.65%27.27%
Oct 06, 2026Truist Financial$310.00$280.2310.62%5.21%
Sep 30, 2026Stifel Nicolaus$330.00$278.8618.34%11.99%
Sep 18, 2026Canaccord Genuity$385.00$280.1437.43%30.66%
Sep 09, 2026Joanne WuenschBMO Capital$317.00$277.8914.07%7.58%
Sep 09, 2026Larry BiegelsenWells Fargo$348.00$276.4325.89%18.10%
Jul 31, 2026Shagun SinghRBC Capital$420.00$321.0930.80%42.54%
Jul 31, 2026Raymond James$370.00$322.6914.66%25.57%
Jul 31, 2026Ryan ZimmermanBTIG$358.00$322.1311.14%21.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 12, 2026BTIGBuyBuyhold
Oct 07, 2026BernsteinMarket PerformMarket Performhold
Oct 06, 2026BarclaysOverweightOverweightinitialise
Oct 06, 2026NeedhamBuyBuyhold
Sep 22, 2026Cowen & Co.HoldHoldhold
Sep 09, 2026BMO CapitalOutperformOutperformhold
Sep 09, 2026Wells FargoOverweightOverweighthold
Aug 13, 2026CitigroupBuyBuyhold
Aug 13, 2026Wolfe ResearchBuyPeer Performdowngrade
Aug 03, 2026CitigroupOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $9 $13 $17 $21 $25 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.29$6.23$8.34$7.86$8.49----
Avg Forecast$9.11$9.18$10.41$12.05$13.49$14.92$16.63$18.36$20.61
High Forecast$9.20$9.30$10.45$12.09$13.62$15.22$17.86$18.71$21.00
Low Forecast$8.97$9.05$10.37$12.02$13.28$14.60$15.65$18.00$20.20
Surprise %-41.93%-32.14%-19.88%-34.77%-37.06%----

Revenue Forecast

$15B $19B $23B $27B $31B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.11B$18.45B$20.50B$22.59B$25.12B----
Avg Forecast$17.06B$18.21B$20.28B$22.52B$24.46B$26.37B$28.62B$31.09B$33.43B
High Forecast$17.18B$18.40B$20.41B$22.64B$24.75B$26.89B$28.69B$31.54B$33.92B
Low Forecast$16.86B$18.02B$20.23B$22.43B$24.17B$25.98B$28.54B$30.61B$32.91B
Surprise %0.29%1.32%1.05%0.32%2.69%----

Net Income Forecast

$2B $3B $4B $6B $7B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.99B$2.36B$3.17B$2.99B$3.25B----
Avg Forecast$1.98B$2.16B$3.17B$4.63B$5.16B$5.72B$6.43B$7.05B$7.91B
High Forecast$2.38B$2.59B$3.80B$4.64B$5.23B$5.84B$6.85B$7.18B$8.06B
Low Forecast$1.59B$1.73B$2.53B$4.61B$5.10B$5.60B$6.01B$6.91B$7.75B
Surprise %0.47%9.14%--35.32%-37.11%----

SYK Forecast FAQ

Is Stryker stock a buy?

Stryker stock has a consensus rating of Buy, based on 52 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 36 Buy, 15 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Stryker is a favorable investment for most analysts.

What is Stryker's price target?

Stryker's price target, set by 52 Wall Street analysts, averages $365.89 over the next 12 months. The price target range spans from $310 at the low end to $420 at the high end, suggesting a potential 24.17% change from the previous closing price of $294.66.

How does Stryker stock forecast compare to its benchmarks?

Stryker's stock forecast shows a 24.17% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.88%).

What is the breakdown of analyst ratings for Stryker over the past three months?

  • October 2026: 25.00% Strong Buy, 53.57% Buy, 21.43% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 25.00% Strong Buy, 53.57% Buy, 21.43% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 25.00% Strong Buy, 57.14% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.

What is Stryker’s EPS forecast?

Stryker's average annual EPS forecast for its fiscal year ending in December 2026 is $14.92, marking a 75.74% increase from the reported $8.49 in 2025. Estimates for the following years are $16.63 in 2027, $18.36 in 2028, and $20.61 in 2029.

What is Stryker’s revenue forecast?

Stryker's average annual revenue forecast for its fiscal year ending in December 2026 is $26.37B, reflecting a 5.01% increase from the reported $25.12B in 2025. The forecast for 2027 is $28.62B, followed by $31.09B for 2028, and $33.43B for 2029.

What is Stryker’s net income forecast?

Stryker's net income forecast for the fiscal year ending in December 2026 stands at $5.72B, representing an 76.26% increase from the reported $3.25B in 2025. Projections indicate $6.43B in 2027, $7.05B in 2028, and $7.91B in 2029.